Genomic diversity of oseltamivir-resistant influenza virus a (H1N1), Luxembourg, 2007-08

Emerging Infectious Diseases

Volumn 15, Issue 9, 2009, Pages 1523-1524

  Gerloff, Nancy A ^a   Kremer, Jacques R ^a   Mossong, Joël ^a   Opp, Matthias ^a   Muller, Claude P ^a  

^a National Public Health Laboratory Luxembourg   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ANTIVIRAL RESISTANCE; DISEASE MARKER; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LETTER; LUXEMBOURG; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS GENOME; VIRUS MUTATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; ENZYME INHIBITORS; GENETIC VARIATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUXEMBOURG; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; OSELTAMIVIR; PHYLOGENY; PREVALENCE; RNA REPLICASE; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

EID: 70249137303     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1509.090452     Document Type: Letter

References (10)

1. Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec. 2008;83:366-372
2. World Health Organization. Influenza A(H1N1) virus resistance to oseltamivir - 2008/2009 influenza season, northern hemisphere [cited 2009 Mar 25]. Available from http://www.who.int/csr/disease/influenza/ H1N1webupdate20090318ed-ns.pdf
3. Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schweiger B, et al. Oseltamivir-resistant influenza A (H1N1) virus, Europe, 2007-08 season. Emerg Infect Dis. 2009;15:552-560 DOI: 10.3201/eid1504.081280
4. Rameix-Welti MA, Enouf V, Cuvelier F, Jeannin P, van der Werf S. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog. 2008;4:e1000103. DOI: 10.1371/journal.ppat.1000103
5. McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003;47:2264-2272 DOI: 10.1128/AAC.47.7.2264-2272.2003 (Pubitemid 36753582)
6. Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, Webster RG, et al. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother. 2005;49:4075-4084 DOI: 10.1128/AAC.49.10.4075-4084.2005 (Pubitemid 41400949)
7. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596-1599 DOI: 10.1093/molbev/msm092 (Pubitemid 47236692)
8. Ronquist F, Huelsenbeck JP. MRBAYES 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003;19:1572-1574 DOI: 10.1093/ bioinformatics/btg180 (Pubitemid 37038874)
9. Guilligay D, Tarendeau F, Resa-Infante P, Coloma R, Crepin T, Sehr P, et al. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol. 2008;15:500-506 DOI: 10.1038/nsmb.1421 (Pubitemid 351653591)
10. Niman H. Emergence and fixing of antiviral resistance in influenza A via recombination and hitch hiking. 2009 Feb 10 [cited 2009 Mar 25]. Available from http://hdl.handle.net/10101/npre.2009.2832.11